By [Andrew Warshauer](/content/author/andrew/ "Posts by Andrew Warshauer"/index.html)
Posted March 31, 2014
In
De Novo Assembly

Cofactor Genomics

Content Overview

Cofactor Genomics is a company that is focused on de novo assembly techniques and advancements in genomics.

Notable Announcements

• Cofactor Genomics, Inc. Announces CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for OncoPrism, its Medicare Approved Immunotherapy Test
• Cofactor Genomics expands clinical use of OncoPrism, as their AI enabled RNA test achieves national clinical validation after predicting immunotherapy response in Lung Cancer Patients
• Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC, a Test Leveraging Novel RNA Modeling Technology to Predict Response to Immunotherapy
• Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics’ Advisory Board as Cofactor Brings OncoPrism test to Partnered Hospitals